Laurent Antoni

875 total citations
15 papers, 684 citations indexed

About

Laurent Antoni is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Laurent Antoni has authored 15 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Laurent Antoni's work include Prostate Cancer Treatment and Research (7 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Cancer, Lipids, and Metabolism (4 papers). Laurent Antoni is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Cancer, Lipids, and Metabolism (4 papers). Laurent Antoni collaborates with scholars based in United Kingdom, Belgium and Germany. Laurent Antoni's co-authors include Michelle D. Garrett, Ian Collins, Nayanta Sodha, Philippa H. Francis‐West, Laurence H. Pearl, Antony W. Oliver, Victoria E. Anderson, John Caldwell, Joy M. Richman and Suresh Nimmagadda and has published in prestigious journals such as Journal of Clinical Oncology, Nature reviews. Cancer and Development.

In The Last Decade

Laurent Antoni

14 papers receiving 671 citations

Peers

Laurent Antoni
Kee Ming Chia Australia
Frank P. Vendetti United States
Danny Rickwood Australia
Rosanna Lacalamita Italy
Jessica Vieusseux Australia
Anne L. Estep United States
Shengyan Xiang United States
Marc Payton United States
Sriganesh Jammula United Kingdom
Sherry A. Weppler Netherlands
Kee Ming Chia Australia
Laurent Antoni
Citations per year, relative to Laurent Antoni Laurent Antoni (= 1×) peers Kee Ming Chia

Countries citing papers authored by Laurent Antoni

Since Specialization
Citations

This map shows the geographic impact of Laurent Antoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Antoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Antoni more than expected).

Fields of papers citing papers by Laurent Antoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Antoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Antoni. The network helps show where Laurent Antoni may publish in the future.

Co-authorship network of co-authors of Laurent Antoni

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Antoni. A scholar is included among the top collaborators of Laurent Antoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Antoni. Laurent Antoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
3.
4.
5.
Boegemann, Martin, Martin Hatzinger, Els Everaert, et al.. (2017). Real-world treatment with abiraterone acetate in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 35(6_suppl). 239–239. 1 indexed citations
6.
Chowdhury, Simon, Alison Birtle, Anders Bjartell, et al.. (2017). Real-world outcomes in first-line treatment of metastatic castration-resistant prostate cancer (mCRPC): The prostate cancer registry.. Journal of Clinical Oncology. 35(6_suppl). 212–212. 3 indexed citations
7.
Chowdhury, Simon, Alison Birtle, Anders Bjartell, et al.. (2017). Real-world outcomes in second-line treatment of metastatic castration-resistant prostate cancer (mCRPC): The Prostate Cancer Registry.. Journal of Clinical Oncology. 35(15_suppl). 5028–5028. 3 indexed citations
8.
Anderson, Victoria E., Michael I. Walton, Paul D. Eve, et al.. (2011). CCT241533 Is a Potent and Selective Inhibitor of CHK2 that Potentiates the Cytotoxicity of PARP Inhibitors. Cancer Research. 71(2). 463–472. 79 indexed citations
9.
Caldwell, John, E. Jane Welsh, Victoria E. Anderson, et al.. (2010). Structure-Based Design of Potent and Selective 2-(Quinazolin-2-yl)phenol Inhibitors of Checkpoint Kinase 2. Journal of Medicinal Chemistry. 54(2). 580–590. 42 indexed citations
10.
Hilton, Stephen T., Sébastien Naud, John Caldwell, et al.. (2009). Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2. Bioorganic & Medicinal Chemistry. 18(2). 707–718. 48 indexed citations
11.
Geetha‐Loganathan, Poongodi, Suresh Nimmagadda, Laurent Antoni, et al.. (2009). Expression of WNT signalling pathway genes during chicken craniofacial development. Developmental Dynamics. 238(5). 1150–1165. 62 indexed citations
12.
Antoni, Laurent, Nayanta Sodha, Ian Collins, & Michelle D. Garrett. (2007). CHK2 kinase: cancer susceptibility and cancer therapy – two sides of the same coin?. Nature reviews. Cancer. 7(12). 925–936. 225 indexed citations
13.
Sun, Xiaoxia, Wei Liu, Di Ai, et al.. (2006). Pitx2promotes development of splanchnic mesoderm-derived branchiomeric muscle. Development. 133(24). 4891–4899. 91 indexed citations
14.
Francis‐West, Philippa H., et al.. (2003). Regulation of myogenic differentiation in the developing limb bud. Journal of Anatomy. 202(1). 69–81. 55 indexed citations
15.
Chen, Miao-Hsueh, Laurent Antoni, Rachid Tazi‐Ahnini, et al.. (2002). Identification of known and novel genes whose expression is regulated by endogenous retinoic acid during early embryonic development of the mouse. Mechanisms of Development. 114(1-2). 205–212. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kee Ming Chia Breakdown of academic impact, for papers by Frank P. Vendetti Breakdown of academic impact, for papers by Danny Rickwood Breakdown of academic impact, for papers by Rosanna Lacalamita Breakdown of academic impact, for papers by Jessica Vieusseux Breakdown of academic impact, for papers by Anne L. Estep Breakdown of academic impact, for papers by Shengyan Xiang Breakdown of academic impact, for papers by Marc Payton Breakdown of academic impact, for papers by Sriganesh Jammula Breakdown of academic impact, for papers by Sherry A. Weppler
Rankless by CCL
2026